Fulminant post-transplant lymphoproliferative disorder presenting with lactic acidosis and acute liver failure.
暂无分享,去创建一个
[1] R. Sokol,et al. Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow up and outcome , 2002, Transplantation.
[2] D. Wigle,et al. Epstein-Barr virus serology and posttransplant lymphoproliferative disease in lung transplantation. , 2001, Transplantation.
[3] K. Welsh,et al. Rising incidence of post‐transplant lymphoproliferative disease in kidney transplant recipients , 2001, The British journal of surgery.
[4] R. Busuttil,et al. Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients. , 1998, Transplantation.
[5] D. Liebowitz. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. , 1998, The New England journal of medicine.
[6] M. Yacoub,et al. A prospective study in heart and lung transplant recipients correlating persistent Epstein-Barr virus infection with clinical events. , 1997, Transplantation.
[7] M. Yacoub,et al. Transmission of donor Epstein-Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients. , 1996, The Journal of general virology.
[8] T. Habermann,et al. Pretransplantation assessment of the risk of lymphoproliferative disorder. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] G Opelz,et al. Feeding the preterm infant , 1993, The Lancet.
[10] A. Friedman,et al. A RECENT DECREASE IN THE TIME TO DEVELOPMENT OF MONOMORPHOUS AND POLYMORPHOUS POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER , 1992, Transplantation.